Agios制药公司内部人出售了大量股份,将其所有权减少15.07%。 Insiders of Agios Pharmaceuticals sold significant shares, reducing their ownership by up to 15.07%.

Agios制药公司的若干内部人士,包括高管和一名董事,于6月24日出售了该公司股票的股份。 Several insiders of Agios Pharmaceuticals, including executives and a director, sold shares of the company's stock on June 24th. 这些销售额在59 701美元至627 198美元之间。 These sales range from $59,701 to $627,198. 在这些交易之后,内幕人士的所有权减少了4.86%至15.07%。 Following these transactions, the insiders' ownership decreased by percentages ranging from 4.86% to 15.07%. Agios制药公司是一家生物制药公司,报告每季度每股损失1.5美元,高于预期,市场上限为19.4亿美元。 Agios Pharmaceuticals, a biopharmaceutical company, reported a better-than-expected quarterly loss of $1.55 per share, with a market cap of $1.94 billion. 分析师对股票的评级是“机动购买”,目标价为58.60美元。 Analysts have a "Moderate Buy" rating on the stock with a target price of $58.60.